Results of a phase 2 study of praluzatamab ravtansine (CX-2009) in patients with advanced breast cancer (ABC)

Kathy Miller, Sara M. Tolaney, Leisha Emens, Sung-Bae Kim, Erika Hamilton, Cristina Saura, Lucia Sanz, Valentina Boni, Filipa Lynce, Juan M. Cejalvo, Jennifer A. Crozier, Shirley Wang, Shannon Tsai, Hojjat Bazzazi, Hirdesh Uppal, Alison Hannah, Sara Hurvitz. Poster presented at the San Antonio Breast Cancer Symposium®, December 6-10, 2022.